Grandfield & Dodd, LLC

SEC CIK: 0001308016
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overview All 13F holders of BMRN Full Q2 2026 holdings

Shares (Q2 2026): 18,243
Value: $1.04M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of BMRN by Grandfield & Dodd, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	18,243	$1.04M	0.1%	+382+2.1%	Added	Holders
Q1 2026	17,861	$1.01M	0.1%	−290−1.6%	Reduced	Holders
Q4 2025	18,151	$1.08M	0.1%	−816−4.3%	Reduced	Holders
Q3 2025	18,967	$1.03M	0.1%	+217+1.2%	Added	Holders
Q2 2025	18,750	$1.03M	0.1%	+38+0.2%	Added	Holders
Q1 2025	18,712	$1.32M	0.1%	+1,320+7.6%	Added	Holders
Q4 2024	17,392	$1.14M	0.1%	+731+4.4%	Added	Holders
Q3 2024	16,661	$1.17M	0.1%	+425+2.6%	Added	Holders
Q2 2024	16,236	$1.34M	0.1%	+109+0.7%	Added	Holders
Q1 2024	16,127	$1.41M	0.1%	+255+1.6%	Added	Holders
Q4 2023	15,872	$1.53M	0.1%	+219+1.4%	Added	Holders
Q3 2023	15,653	$1.38M	0.1%	−125−0.8%	Reduced	Holders
Q2 2023	15,778	$1.37M	0.1%	+137+0.9%	Added	Holders
Q1 2023	15,641	$1.52M	0.1%	+231+1.5%	Added	Holders
Q4 2022	15,410	$1.59M	0.1%	+1,037+7.2%	Added	Holders
Q3 2022	14,373	$1.22M	0.1%	+372+2.7%	Added	Holders
Q2 2022	14,001	$1.16M	0.1%	+75+0.5%	Added	Holders
Q1 2022	13,926	$1.07M	0.1%	+456+3.4%	Added	Holders
Q4 2021	13,470	$1.19M	0.1%	+1,337+11.0%	Added	Holders
Q3 2021	12,133	$940.0K	0.1%	+399+3.4%	Added	Holders
Q2 2021	11,734	$980.0K	0.1%	+215+1.9%	Added	Holders
Q1 2021	11,519	$870.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.